Daphne N Weemering

8PUBLICATIONS
15CO-AUTHORS
Pharmaceutical delivery technologiesSpeech pathologyEuropean history (excl. British, classical Greek and Roman)Epidemiological methodsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 20, 2026
Clinical drug development in amyotrophic lateral sclerosis: industry-reported challenges and opportunities.

|Apr 21, 2026
Heterogeneity in the Analysis of the ALSFRS-R in ALS Clinical Trials and its Effect on the Validity and Precision of Trial Conclusions.

|May 06, 2025
Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant Study.

Ruben P A van Eijk, Daphne N Weemering, Sarah Opie-Martin

|Dec 12, 2024
Attrition and discontinuation in amyotrophic lateral sclerosis clinical trials: a meta-analysis.

Ruben P A van Eijk, Floris T van Loon, Jordi W J van Unnik

|Jun 03, 2024
Trial Participation in Neurodegenerative Diseases: Barriers and Facilitators: A Systematic Review and Meta-Analysis.

Daphne N Weemering, Anita Beelen, Tessa Kliest

|Aug 08, 2023
A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis.

Daphne N Weemering, Mark Midei, Peter Milner

Pageof 2

Frequent Collaborators

8 joint publications

Ruben P A van Eijk

4 joint publications

Leonard H van den Berg

3 joint publications

Jordi W J van Unnik

2 joint publications

Leonard H van den Berg